NAMS Menopause
Certification Exam 2026
Practice Questions, Answers &
Study Guide PDF
Median age of natural menopause - ANSWER-51 years
Characteristic hormonal change in menopause transition - ANSWER-Declining
estrogen
Reproductive stage of a 49-year-old with irregular periods and vasomotor
symptoms - ANSWER-Perimenopause
Definition of postmenopause - ANSWER-12 consecutive months without
menstruation
Laboratory finding supporting menopause diagnosis in a 52-year-old woman -
ANSWER-Elevated FSH (>25 IU/L)
Most effective treatment for moderate-to-severe hot flashes - ANSWER-Hormone
therapy
, Hormone therapy regimen for postmenopausal woman with intact uterus -
ANSWER-Estrogen plus progestogen
Recommended treatment for hot flashes in breast cancer survivor - ANSWER-
Paroxetine
Contraindication for systemic hormone therapy - ANSWER-Unexplained vaginal
bleeding
Non-hormonal medication effective for menopausal sleep disturbances -
ANSWER-Gabapentin
Primary risk factor for osteoporosis in postmenopausal women - ANSWER-
Estrogen deficiency
Diagnosis for a 60-year-old woman with a T-score of -2.8 on DEXA scan - ANSWER-
Osteoporosis
Gabapentin - ANSWER-Improves sleep and reduces hot flashes in menopausal
women.
T-score of -2.8 on DEXA scan - ANSWER-Indicates osteoporosis.
First-line medication for postmenopausal osteoporosis treatment - ANSWER-
Bisphosphonates.
Certification Exam 2026
Practice Questions, Answers &
Study Guide PDF
Median age of natural menopause - ANSWER-51 years
Characteristic hormonal change in menopause transition - ANSWER-Declining
estrogen
Reproductive stage of a 49-year-old with irregular periods and vasomotor
symptoms - ANSWER-Perimenopause
Definition of postmenopause - ANSWER-12 consecutive months without
menstruation
Laboratory finding supporting menopause diagnosis in a 52-year-old woman -
ANSWER-Elevated FSH (>25 IU/L)
Most effective treatment for moderate-to-severe hot flashes - ANSWER-Hormone
therapy
, Hormone therapy regimen for postmenopausal woman with intact uterus -
ANSWER-Estrogen plus progestogen
Recommended treatment for hot flashes in breast cancer survivor - ANSWER-
Paroxetine
Contraindication for systemic hormone therapy - ANSWER-Unexplained vaginal
bleeding
Non-hormonal medication effective for menopausal sleep disturbances -
ANSWER-Gabapentin
Primary risk factor for osteoporosis in postmenopausal women - ANSWER-
Estrogen deficiency
Diagnosis for a 60-year-old woman with a T-score of -2.8 on DEXA scan - ANSWER-
Osteoporosis
Gabapentin - ANSWER-Improves sleep and reduces hot flashes in menopausal
women.
T-score of -2.8 on DEXA scan - ANSWER-Indicates osteoporosis.
First-line medication for postmenopausal osteoporosis treatment - ANSWER-
Bisphosphonates.
